Milad Besharatifard·Oct 31Herbal Medicine Has a Registry ProblemMost countries now regulate herbal medicines. Very few record what those medicines do to people. Here is why that gap matters, and where it…A response icon1
Vikas Chander, PhD·Sep 8Are You Part of the World’s Largest Medical Experiment?The Hidden Science Behind Drug Safety, Real-World Evidence, and Post-Approval Surveillance
Peter Friebe·Jul 28Access to Peptides: Approved or NotDisclosure: I wrote this article and used AI as a “professional editor” to refine and shorten overly long or complicated sentences.
InThe Quantastic JournalbyRené F. Najera, MPH, DrPH·Jul 25Peptides, Wellness Hype, and the FDA: Separating Evidence-Based Treatments From Risky Online TrendsFrom semaglutide to tanning shots, peptides sit between rigorous drug development and an unregulated wellness boom.A response icon1
vinay dahiya·Jun 25The Biosimilar Boom Is Here: Is Pharmacovigilance Ready?As blockbuster biologic drugs lose patent protection, biosimilars are transforming global healthcare. But while patients gain access to…
